Arcturus Therapeutics Holdings (ARCT) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Sep 2025 value amounting to -$0.49.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) fell 88.46% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.46, marking a year-over-year decrease of 5.13%. This contributed to the annual value of -$3 for FY2024, which is 167.86% down from last year.
- Latest data reveals that Arcturus Therapeutics Holdings reported EPS (Weighted Average and Diluted) of -$0.49 as of Q3 2025, which was down 44.12% from -$0.34 recorded in Q2 2025.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $4.44 during Q4 2022, with a 5-year trough of -$2.15 in Q2 2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.50, with a median of -$0.52 in 2025.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) soared by 402.04% in 2022, and later slumped by 153.48% in 2024.
- Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) stood at -$1.47 in 2021, then surged by 402.04% to $4.44 in 2022, then crashed by 109.91% to -$0.44 in 2023, then tumbled by 152.27% to -$1.11 in 2024, then plummeted by 88.46% to -$0.49 in 2025.
- Its last three reported values are -$0.49 in Q3 2025, -$0.34 for Q2 2025, and -$0.52 during Q1 2025.